SUBSCRIBE: eNewsletter
Ophthalmology Times' David Hutton speaks with Michael Saidel, MD, a cornea and cataract specialist, on his presentation regarding "Evolution of an administration technique for DEXYCU (dexamethasone intraocular suspension) 9%" dur
Edward Holland, MD, director of Cornea Services at Cincinnati Eye Institute, speaks with Ophthalmology Times' David Hutton on the results of a clinical trial using KP1-121 0.25% (loteprednol etabonate) for dry eye treatment durin
Ophthalmology Times' Sheryl Stevenson speaks with Julie Speed, chief commercial officer of Eyevance Pharmaceuticals, on what's on the agenda for the company's porfolio this year with product launches during the 2020 ASCRS virtual
Sanjay N.
Ophthalmology Times' David Hutton speaks with John A.
Ophthalmology Times' Sheryl Stevenson speaks with Kala Pharmaceuticals' James Yanek, director of professional relations, and Desiree Owen, OD, associate director of Medical Science Liaisons at
Ophthalmology Times' David Hutton speaks with Cynthia Matossian, MD, FACS, on her presentation "Real-world efficacy of DEXYCU (dexamethasone intra
Ophthalmology Times' Sheryl Stevenson speaks with Shervin Korangy, president and CEO of BVI Medical, on the latest updates and products in the pipeline for the company, how they're assisting with and providing resources for healt
Ophthalmology Times' Sheryl Stevenson speaks with Roger Kennedy, director of marketing at Bio-Tissue, on the company's research posters presented at the 2020 ASCRS virtual meeting, as well as updates on operations amid the corona
Denise Visco, MD, speaks with Ophthalmology Times Executive Editor David Hutton on the findings from her poster on the effects of intracameral phenylephrine/ke
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
